التفاصيل البيبلوغرافية
| العنوان: |
Costs of oropharyngeal squamous cell cancer treatment in Finland |
| المؤلفون: |
Tikkanen, Juhana, Nieminen, Teija, Lassus, Patrik, Tenhunen, Mikko, Lehtonen, Lasse, Makitie, Antti |
| المساهمون: |
HUS Head and Neck Center, Korva-, nenä- ja kurkkutautien klinikka, Anestesiologian yksikkö, HUS Emergency Medicine and Services, HUS Musculoskeletal and Plastic Surgery, Clinicum, Plastiikkakirurgian yksikkö, HUS Comprehensive Cancer Center, Department of Oncology, HUSLAB, HUS Diagnostic Center, Research Programs Unit, Research Program in Systems Oncology |
| بيانات النشر: |
Springer |
| سنة النشر: |
2023 |
| المجموعة: |
Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto |
| مصطلحات موضوعية: |
Chemotherapy, Head and neck cancer, Microvascular reconstruction, Outcome, Radiotherapy, Surgery, 3125 Otorhinolaryngology, ophthalmology |
| الوصف: |
BackgroundOropharyngeal squamous cell carcinoma (OPSCC) can be treated with definitive (chemo)radiotherapy ((C)RT) or primary surgical treatment (PST) with or without postoperative oncologic treatment. The prognosis of OPSCC does not essentially depend on the treatment modality, which allows to consider secondary decision-making aspects such as treatment costs when recommending an individual treatment modality. We attempted to analyze the costs associated with definitive (C)RT and PST in the treatment of OPSCC in Finland.Materials and methodsWe included 73 patients diagnosed with OPSCC at the Helsinki University Hospital (HUS) (Helsinki, Finland) in 2019 and 2020. Treatment costs were defined as the costs incurred in the specialized medical care during the first 12 months after the diagnosis was established.ResultsDefinitive RT and definitive CRT were on a 1-year horizon associated with median costs of approximately 10 700euro and 13 300euro, respectively; while, the median costs of PST equaled about 40 600euro. The costs of definitive (C)RT mostly consisted of the costs of (chemo)radiotherapy sessions; while, the operating room costs and the costs of intensive care and stay on a ward drove the costs of PST.ConclusionsPST is associated with 2-3 times higher median costs than definitive (C)RT in Finland. The finding differs from the results previously reported in North America, which is related, e.g., to differences in the treatment practices as well as in the regulation of the health care systems. ; Peer reviewed |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
application/pdf |
| اللغة: |
English |
| العلاقة: |
Open Access funding provided by University of Helsinki including Helsinki University Central Hospital. This research was funded by Helsingin ja Uudenmaan Sairaanhoitopiiri and Finska Lakaresallskapet; Tikkanen , J , Nieminen , T , Lassus , P , Tenhunen , M , Lehtonen , L & Makitie , A 2023 , ' Costs of oropharyngeal squamous cell cancer treatment in Finland ' , European Archives of Oto-Rhino-Laryngology , vol. 280 , pp. 5499–5506 . https://doi.org/10.1007/s00405-023-08124-4Test; ORCID: /0000-0002-3443-3838/work/147913899; fce7cd46-afd4-43d3-9d0d-30408ecc40b4; http://hdl.handle.net/10138/567759Test; 001035717900001 |
| الإتاحة: |
http://hdl.handle.net/10138/567759Test |
| حقوق: |
openAccess ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: |
edsbas.2956AB63 |
| قاعدة البيانات: |
BASE |
